Current perspectives of bacteriophage therapy for multidrug-resistant wound infections
Michał Wójcicki1, Iwona Gientka2, Andrzej Górski1,3,4
1Bacteriophage Laboratory, Department of Phage Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.
Introduction:
The global rise in MDR bacterial infections has made the treatment of chronic and acute wound infections increasingly challenging. Conventional antibiotics often fail, leading to delay healing, more complications, and higher healthcare costs.
Areas Covered:
This review explores the current state of phage therapy as an alternative or adjunct to antibiotics for MDR-infected wounds. It summarizes types of wound infections, current treatment protocols, and recent clinical studies using phage therapy. This review also discusses the advantages of personalized phage preparations and highlights innovative local delivery methods. References were identified through a structured search of recent peer-reviewed studies and case reports in PubMed.
Expert Opinion:
Phage therapy shows promise against antimicrobial-resistant wound infections. Although clinical outcomes are encouraging, its widespread use is limited by legal, technical, and awareness barriers. Future success in the treatment of wound infections with phage therapy will depend on the development of standardized protocols, rapid diagnostics tools, and large-scale clinical trials - challenges that also apply broadly to phage therapy in other clinical contexts. Phage therapy, especially in local applications, aligns well with the principles of personalized medicine and may become a valuable component of modern wound care within the next decade.
Insights
Phage therapy offers a promising alternative for treating drug-resistant wound infections when antibiotics fail. Overcoming regulatory and technical hurdles could establish phage therapy as a key component of future wound care.
Area of Science:
- Microbiology
- Infectious Diseases
- Wound Care
Background:
- The rise of multidrug-resistant (MDR) bacterial infections presents significant challenges in treating chronic and acute wound infections.
- Conventional antibiotic treatments are increasingly failing, leading to prolonged healing, increased complications, and escalating healthcare expenses.
Purpose of the Study:
- To review the current status of phage therapy as a potential alternative or adjunct to antibiotics for MDR-infected wounds.
- To summarize wound infection types, existing treatment protocols, and recent clinical applications of phage therapy.
Main Methods:
- A structured literature search was conducted in PubMed, focusing on recent peer-reviewed studies and case reports.
- The review synthesizes information on phage therapy's efficacy, personalized approaches, and novel local delivery systems.
Main Results:
- Phage therapy demonstrates potential in combating antimicrobial-resistant wound infections, with encouraging clinical outcomes.
- Personalized phage preparations and innovative local delivery methods are highlighted as key advancements.
Conclusions:
- Despite promising results, widespread adoption of phage therapy is hindered by legal, technical, and awareness barriers.
- Standardized protocols, rapid diagnostics, and large-scale clinical trials are crucial for the future success of phage therapy in wound care, potentially integrating it into personalized medicine approaches within ten years.
Related Concept Videos
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
DNA Bacteriophages
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...


